81 related articles for article (PubMed ID: 9447955)
1. The human hexokinase II gene promoter: functional characterization and detection of variants among patients with NIDDM.
Malkki M; Laakso M; Deeb SS
Diabetologia; 1997 Dec; 40(12):1461-9. PubMed ID: 9447955
[TBL] [Abstract][Full Text] [Related]
2. Nuclear protein binding and functional activity of a variant insulin gene found in non-insulin-dependent diabetes mellitus.
Yildiz N; Diedrich T; Knepel W
Exp Clin Endocrinol Diabetes; 1996; 104(3):218-27. PubMed ID: 8817239
[TBL] [Abstract][Full Text] [Related]
3. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and analysis of the human cardiac sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2) gene promoter.
Wankerl M; Boheler KR; Fiszman MY; Schwartz K
J Mol Cell Cardiol; 1996 Oct; 28(10):2139-50. PubMed ID: 8930809
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional characterizations of the 5'-flanking region of the mouse glucagon receptor gene: comparison with the rat gene.
Geiger A; Decaux JF; Burcelin R; Le Cam A; Salazar G; Charron MJ; Girard J; Kervran A
Biochem Biophys Res Commun; 2000 Jun; 272(3):912-21. PubMed ID: 10860851
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the infection-responsive bovine lactoferrin promoter.
Zheng J; Ather JL; Sonstegard TS; Kerr DE
Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
[TBL] [Abstract][Full Text] [Related]
7. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
8. A short region of the promoter of the breast cancer associated PLU-1 gene can regulate transcription in vitro and in vivo.
Catteau A; Rosewell I; Solomon E; Taylor-Papadimitriou J
Int J Oncol; 2004 Jul; 25(1):5-16. PubMed ID: 15201984
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
[TBL] [Abstract][Full Text] [Related]
11. Isolation of the promoter for Type I hexokinase from rat.
White JA; Liu W; Wilson JE
Arch Biochem Biophys; 1996 Nov; 335(1):161-72. PubMed ID: 8914847
[TBL] [Abstract][Full Text] [Related]
12. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
13. Two Sp sites are important cis elements regulating the upstream promoter region of the gene for rat type I hexokinase.
Liu W; Wilson JE
Arch Biochem Biophys; 1997 Oct; 346(1):142-50. PubMed ID: 9328294
[TBL] [Abstract][Full Text] [Related]
14. Characterization of putative cis-regulatory elements that control the transcriptional activity of the human Oct4 promoter.
Yang HM; Do HJ; Oh JH; Kim JH; Choi SY; Cha KY; Chung HM; Kim JH
J Cell Biochem; 2005 Nov; 96(4):821-30. PubMed ID: 16149048
[TBL] [Abstract][Full Text] [Related]
15. Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene.
Iwamoto K; Mori H; Okazawa H; Hashiramoto M; Kasuga M
Diabetologia; 2002 Aug; 45(8):1182-95. PubMed ID: 12189449
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
17. Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes.
Cusi KJ; Pratipanawatr T; Koval J; Printz R; Ardehali H; Granner DK; Defronzo RA; Mandarino LJ
Metabolism; 2001 May; 50(5):602-6. PubMed ID: 11319725
[TBL] [Abstract][Full Text] [Related]
18. Variant sequences of the Hexokinase II gene in familial NIDDM.
Taylor RW; Printz RL; Armstrong M; Granner DK; Alberti KG; Turnbull DM; Walker M
Diabetologia; 1996 Mar; 39(3):322-8. PubMed ID: 8721778
[TBL] [Abstract][Full Text] [Related]
19. Functional consequences of naturally occurring variants of human hexokinase II.
Malkki M; Laakso M; Deeb SS
Diabetologia; 1998 Oct; 41(10):1205-9. PubMed ID: 9794109
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb.
Pirinen E; Heikkinen S; Malkki M; Deeb SS; Jänne J; Laakso M
Biochim Biophys Acta; 2004 Jan; 1676(2):149-54. PubMed ID: 14746909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
